The cost of a manufacturing plant for commercial q
Post# of 15624
In OWCP's case, they already have Emilia geared up to make commercial quantities of the cream, I'm uncertain about the sublingual tablet. They have Mediq for German sales and distribution, and I believe they have options for the rest of Europe.
Certainly OWCP has much further room for growth in partnering it's products, but I believe we'll learn more after the Phase 1 trial results are known.
If in fact Mediq is able to put the cream on sale in German based on results of the trial, the stock should approach the billion dollar market cap on initiation of sales IMHO. That could occur by early next year if additional trials are not needed.
Gary